Journal
BIOANALYSIS
Volume 8, Issue 19, Pages 1997-2005Publisher
FUTURE SCI LTD
DOI: 10.4155/bio-2016-0086
Keywords
endogenous biomarker; fit-for-purpose validation; LC-MS/MS; surrogate analyte
Funding
- Bristol-Myers Squibb Company
Ask authors/readers for more resources
Background: Creatinine is an endogenous compound generated from creatine by normal muscular metabolism. It is an important indicator of renal function and the serum level is routinely monitored in clinical labs. Results & methodology: Surrogate analyte (d3-creatinine) was used for calibration standard and quality control preparation and the relative instrument response ratio between creatinine and d3-creatinine was used to calculate the endogenous creatinine concentrations. Conclusion: A fit-for-purpose strategy of using a surrogate analyte and authentic matrix was adopted for this validation. The assay was the first human plasma assay using such strategy and was successfully applied to a clinical study to confirm a transient elevation of creatinine observed using an existing clinical assay.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available